ISIS PHARMACEUTICAL (NASDAQ:ISIS)

View All ReportsStreetInsider.com Reports on ISIS

Dec 21, 2009 08:18 AM Isis Pharmaceuticals (ISIS) To Receive $10M from OncoGenex (OGXI) and Teva (TEVA) OGX-011 Licensing Agreement

Dec 17, 2009 08:47 AM Regulus Therapeutics Obtains microRNA Exclusive Rights (ALNY, ISIS)

Dec 15, 2009 08:23 AM Isis Pharma (ISIS) and Alnylam Pharma (ALNY) Receive a Notice of Allowance from U.S. FDA for "Crooke" Patent Family

Dec 4, 2009 07:27 AM Isis Pharmaceuticals (ISIS) volatility elevated; shares near 30-month low

Dec 3, 2009 08:26 AM Isis Pharma (ISIS) Announces the Development of Two New Drugs

View All Press ReleasesCompany Press Releases on ISIS

Jan 25, 2010 08:00AM Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21

Jan 15, 2010 07:00AM Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium

Jan 11, 2010 09:30AM Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development

Jan 11, 2010 09:00AM Isis Pharmaceuticals Adds New Cardiovascular Drug to Development Pipeline

Jan 6, 2010 07:00AM Isis Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

StreetInsider Reports on ISIS by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on ISIS

Dec 30, 2009 07:42 AM How Isis Benefits Teva-OncoGenex Deal

Dec 28, 2009 03:47 PM Teva Expands Cancer Portfolio

Dec 24, 2009 08:13 AM Teva Deal a Reality Check for OncoGenex Investors

Dec 14, 2009 04:32 AM Making and Breaking Biotech Deals

Nov 25, 2009 07:31 AM Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate

View All FilingsSEC Filings on ISIS

Feb 1, 2010 04:35PM Form 4 ISIS PHARMACEUTICALS For: Jan 29 Filed by: PARSHALL B LYNNE

Jan 29, 2010 02:53PM Form SC 13G ISIS PHARMACEUTICALS Filed by: BlackRock Inc.

Jan 5, 2010 07:31PM Form 4 ISIS PHARMACEUTICALS For: Jan 01 Filed by: BENNETT C FRANK

Jan 5, 2010 07:30PM Form 4 ISIS PHARMACEUTICALS For: Jan 04 Filed by: PARSHALL B LYNNE

Jan 5, 2010 07:29PM Form 4 ISIS PHARMACEUTICALS For: Jan 01 Filed by: Geary Richard S

View All Comments Comments on recent ISIS articles

sarahzhu
on Feb 1, 2010
at 10:15 PM discount christian louboutin Christian Louboutin's designs have gained popularity among socialites and celebrities, several of whom have made public appearances sporting the signature red soles. For example, Christina Aguilera and Nicole Kidman were outfitted by the couture cobbler for their weddings.The Website including http://www.louboutindiscounting.com
Article: Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)

sarah
on Feb 1, 2010
at 10:10 PM thanks l like to pursuit of fashion,discount christian louboutinanddiscount christian louboutin pumpsare my favorite
Article: Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)

saddsa
on Dec 26, 2009
at 01:12 AM dsadsa Hi,dear friend: let you a exicited place! http://www.fendsell.com http://www.grownproducts.com cheap christian louboutin shoes wholesale louis vuitton handbags replica gucci shoes and bags discount UGG
Article: Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)

Reality
on Jul 9, 2008
at 03:43 PM Reading Comprehension ISIS has been around awhile (20 years?). How short term are you talking? While the stock might not be "BLAZING HOTT", it's not garbage either. You might want to reevaluate your position. Did you even read the announcement?
Article: ISIS Pharmaceuticals (ISIS) Subsidiary, Ibis Biosciences, Receives Additional $20M Investment from Abbott

Truth
on Jul 3, 2008
at 06:07 PM idiot This guy is an idiot. ISIS is a garbage company that is only here for the shorterm.
Article: ISIS Pharmaceuticals (ISIS) Subsidiary, Ibis Biosciences, Receives Additional $20M Investment from Abbott

Comments on ISIS

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?